Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01710345Phase 2Completed
A Phase 2 trial of sufentanil in acute pain, sponsored by Talphera. Started Oct 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01710345.